Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Institut Claudius Regaud
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Johnson & Johnson Enterprise Innovation Inc.
University of Pittsburgh
Sun Yat-sen University
City of Hope Medical Center
NRG Oncology
NRG Oncology
NRG Oncology
Eastern Cooperative Oncology Group
H. Lee Moffitt Cancer Center and Research Institute
Eastern Cooperative Oncology Group
M.D. Anderson Cancer Center
University of Texas Southwestern Medical Center
Sun Yat-sen University
M.D. Anderson Cancer Center
First Affiliated Hospital of Guangxi Medical University
University of Michigan Rogel Cancer Center
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
Abramson Cancer Center at Penn Medicine
University of Texas Southwestern Medical Center
M.D. Anderson Cancer Center
Mayo Clinic
National Cancer Institute (NCI)
Jonsson Comprehensive Cancer Center
Sun Yat-sen University
UNC Lineberger Comprehensive Cancer Center
Sun Yat-sen University
Washington University School of Medicine
Shandong Cancer Hospital and Institute
Radiation Therapy Oncology Group
Radiation Therapy Oncology Group
NYU Langone Health
Rigshospitalet, Denmark
Jiangsu Cancer Institute & Hospital
M.D. Anderson Cancer Center
Sun Yat-sen University
Mayo Clinic
Emory University
NRG Oncology
EMD Serono
University of Pittsburgh